A carregar...

New Receptor Targets for Medical Therapy in Irritable Bowel Syndrome

BACKGROUND: Despite setbacks to the approval of new medications for the treatment of irritable bowel syndrome, interim guidelines on endpoints for IBS trials have enhanced interest as new targets for medical therapy are proposed based on novel mechanisms or chemical entities. AIM: To review the appr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Camilleri, Michael
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2896496/
https://ncbi.nlm.nih.gov/pubmed/19785622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2036.2009.04153.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!